Diamond Biofund conducted its carbon emissions assessment in accordance with the ISO 14064-1:2018 standard, applying the operational control approach to include emissions within the defined boundary. The calculation is based on the Global Warming Potential (GWP) values from the IPCC AR6. The organizational boundary covers the parent entity of Diamond Biofund and its subsidiaries included in the consolidated financial statements (currently, there are no such subsidiaries).
In June 2024, Diamond Biofund conducted its first greenhouse gas inventory for FY2023, covering the parent company and its subsidiaries. To ensure the transparency and accuracy of carbon emission data, third-party verification is conducted annually. The 2024 greenhouse gas inventory was verified by AFNOR ASIA in accordance with the ISO 14064-3:2019 standard.
| 2023 | 2024 | |
|---|---|---|
| Scope 1 Emissions (metric tons CO₂e) | 6.8150 | 11.5250 |
| Scope 2 Emissions (metric tons CO₂e) | 60.8820 | 82.1897 |
| Scope 3 Emissions (metric tons CO₂e) | 365.6920 | 278.3027 |
| – Business Travel – Upstream Leased Assets (Note 1) – Investment |
33.8610 62.1260 269.7050 |
33.7742 123.0591 121.4695 |
| Carbon Footprint Intensity (Scopes 1 & 2) (metric tons CO2e per million AUM)(Note 2) | 0.0063 | 0.0128 |
| Carbon Footprint Intensity (Scope 3) (metric tons CO2e per million AUM) (Note 2) | 0.0339 | 0.0382 |
| Data Coverage Rate (Note 3) | 100% | 100% |
Note 1: This item refers to the shared electricity consumption of leased office premises and, as of 2024, has been reclassified under 「Upstream Leased Assets」 (previously listed under 「Fuel and Energy Activities」).
Note 2: The Company’s operating income for 2023 and 2024 was negative; therefore, intensity is calculated based on carbon emissions per million of Assets Under Management (unit: metric tons CO₂e per million AUM).
Note 3: Data coverage rate is the proportion of operational sites included in the Scope 1 and 2 inventory relative to total operational sites for the year.
Note 4: Quantification method: GHG emissions = Energy consumption × Emission factor × Global Warming Potential (GWP).
Note 5: Calculations are based on the 2024 Greenhouse Gas Emission Factor Table announced by the Ministry of Environment.
| 【Scope 1、2】Operation | Adopt an absolute reduction method using 2024 as the base year, aiming to reduce Scope 1 and Scope 2 greenhouse gas (GHG) absolute emissions by 25% by 2030. In the long term, the Company aims to align with the 2050 net-zero emissions target. |
| 【Scope 3】Investment | Using the engagement approach, by 2030, 33% of the book value of Diamond Biofund’s investment portfolio must either have committed to or established their own carbon reduction targets. |
Diamond Biofund uses water resources solely for cleaning, domestic sewage, and drinking purposes. In 2024, the total water consumption was 2,566 cubic meters. With 25 employees, this equates to an average daily water usage of approximately 281 liters per person, which is lower than the average of 330 liters per person per day in Taipei City. Wastewater is discharged into the municipal sewage system and is not included in the statistical calculation.
Water consumption data for the past two years is summarized as follows:
Unit: Cubic meters (m³)
| Office site | 2023 | 2024 |
|---|---|---|
| Xinyinote | 993 | 77 |
| Zhongxiao | 538 | 2,489 |
| Total | 1,531 | 2,566 |
Note: The Xinyi office underwent facility restoration in January and February 2024, and the lease was officially terminated on February 29, 2024.
Diamond Biofund relocated to the Zhongxiao office in January 2024. During the renovation of the new office, water-saving devices—such as low-flow faucets and automatic flush systems—were installed. Based on the water consumption at the Zhongxiao office in 2024, Diamond Biofund has set 2024 as the baseline year and established a target to reduce total water consumption by 10% by 2030. Continue to remind colleagues to conserve water through education and training as well as daily awareness initiatives.
醣基生醫股份有限公司
2017年9月27日登錄興櫃市場交易 (6586:TT)
公司所在地
台北,台灣
公司設立日期
2013
登錄公開市場
2017
公司官網
https://www.chopharma.com/cn/index.html